Ignite Creation Date:
2024-07-17 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06497673
Status:
ENROLLING_BY_INVITATION
Last Update Posted:
2024-07-12
First Post:
2024-07-04
Brief Title:
Sanger Human Cell Atlasing Project
Sponsor:
Organization:
The Wellcome Sanger Institute
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
False
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITH_DNA
Bio Spec Description:
Samples will include whole or dissected tissues frozen or fixed samples single cell suspension andor purified nucleic acids Peripheral blood mononuclear cells PBMCs primary human umbilical vein endothelial cells HUVEC whole blood bone marrow urine tissue samples and cell lines Fetal samples will be received up to 24 weeks post conception
Enrollment Count:
4000
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Time Perspective List:
Who Masked List: